The leaders ofthe St. Jude Comprehensive Cancer Center (SJCCC) are responsible for setting the Center's strategic goals and establishing a laboratory and clinical research environment that can realize its cancer focused mission. The SJCCC administrative staff provide logistical support to this mission;implementing the plans and policies established to ensure an efficient and productive Center. The Office of SJCCC Administration works closely with the SJCCC Director, Associate Directors of the SJCCC, the Center Program leaders, and Shared Resource Leaders to provide support for the functions required for efficient operation of all Center activities, including the day-to-day operations of the SJCCC Director's office. The Center administration works with the Director to develop and manage all fiscal activities;provide oversight of Center institutional and external funds;participate in the development and oversight of the research support infrastructure;develop, implement, and maintain policies and procedures;coordinate the submission of grants and related site visits;and serve as a liaison to and primary point of contact with both internal units and external agencies. Funding from the CCSG supports a percentage of the salary of the Center Administrator, the Director's Executive Associate, and other administrative staff.
The Office of Administration coordinates and manages services important for the efficient and productive functioning of the SJCCC. This role is crucial in the global effort to advance the research and treatment of pediatric malignant diseases.
|Wu, Jianrong (2015) Power and sample size for randomized phase III survival trials under the Weibull model. J Biopharm Stat 25:16-28|
|Serinagaoglu, Yelda; Paré, Joshua; Giovannini, Marco et al. (2015) Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development. Dev Biol 398:97-109|
|Kimberg, Cara I; Klosky, James L; Zhang, Nan et al. (2015) Predictors of health care utilization in adult survivors of childhood cancer exposed to central nervous system-directed therapy. Cancer 121:774-82|
|Bhojwani, Deepa; McCarville, Mary B; Choi, John K et al. (2015) The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol 168:845-53|
|Chamdine, Omar; Gaur, Aditya H; Broniscer, Alberto (2015) Effective treatment of cerebral mucormycosis associated with brain surgery. Pediatr Infect Dis J 34:542-3|
|Karol, Seth E; Coustan-Smith, Elaine; Cao, Xueyuan et al. (2015) Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. Br J Haematol 168:94-101|
|Chan, W K; Suwannasaen, D; Throm, R E et al. (2015) Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity. Leukemia 29:387-95|
|Gawade, Prasad L; Oeffinger, Kevin C; Sklar, Charles A et al. (2015) Lifestyle, distress, and pregnancy outcomes in the Childhood Cancer Survivor Study cohort. Am J Obstet Gynecol 212:47.e1-10|
|Momani, Tha'er G; Mandrell, Belinda N; Gattuso, Jami S et al. (2015) Children's perspective on health-related quality of life during active treatment for acute lymphoblastic leukemia: an advanced content analysis approach. Cancer Nurs 38:49-58|
|Dodd, K; Nance, S; Quezada, M et al. (2015) Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity. Oncogene 34:1312-22|
Showing the most recent 10 out of 5513 publications